Protara Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Protara Therapeutics (Nasdaq: TARA) said management will present at two investor conferences in late February and early March 2026.

Virtual fireside chat at the Oppenheimer 36th Annual Healthcare Life Sciences Conference is scheduled for Feb 26, 2026 at 2:40 PM ET, and an in-person fireside chat at TD Cowen 46th Annual Health Care Conference is scheduled for Mar 3, 2026 at 2:30 PM ET in Boston. Live webcasts and limited-time archives are available via the company’s Events and Presentations webpage.

Market Reaction

+6.30% $7.09

15m delay 11 alerts

+6.30% Since News

$7.09 Last Price

$6.53 $7.15 Day Range

+$23M Valuation Impact

$380M Market Cap

0.7x Rel. Volume

Following this news, TARA has gained 6.30%, reflecting a notable positive market reaction. Our momentum scanner has triggered 11 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $7.09. This price movement has added approximately $23M to the company's valuation.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Silver for real-time data.

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:

• Oppenheimer 36th Annual Healthcare Life Sciences Conference. A fireside chat will take place virtually on Thursday, February 26 at 2:40 pm ET.
• TD Cowen 46th Annual Health Care Conference. A fireside chat will take place on Tuesday, March 3 at 2:30 pm ET in Boston.

A live webcast of the events can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcasts will be archived for a limited time following the presentation.

About Protara Therapeutics, Inc.

Protara is a clinical-stage biotechnology company committed to advancing transformative therapies for people with cancer and rare diseases. Protara’s portfolio includes its lead candidate, TARA-002, an investigational cell-based therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs). The Company is evaluating TARA-002 in an ongoing Phase 2 trial in NMIBC patients with carcinoma in situ (CIS) who are unresponsive or naïve to treatment with Bacillus Calmette-Guérin, as well as a Phase 2 trial in pediatric patients with LMs. Additionally, Protara is developing IV Choline Chloride, an investigational phospholipid substrate replacement for patients on parenteral nutrition who are otherwise unable to meet their choline needs via oral or enteral routes. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

When will Protara Therapeutics (TARA) present at the Oppenheimer conference?

Protara will hold a virtual fireside chat on Feb 26, 2026 at 2:40 PM ET. According to the company, the session is part of Oppenheimer’s 36th Annual Healthcare Life Sciences Conference and will be available via a live webcast on the company Events and Presentations page.

How can investors watch the Protara (TARA) TD Cowen presentation on March 3, 2026?

Investors can attend in person in Boston or watch via webcast where available. According to the company, the TD Cowen fireside chat on Mar 3, 2026 at 2:30 PM ET will be webcast and later archived for a limited time on the Events and Presentations webpage.

Will Protara Therapeutics (TARA) archive the webcasts from the investor conferences?

Yes, the company will archive the webcasts for a limited time after each presentation. According to the company, recordings of the Feb 26 and Mar 3 sessions will be posted in the Events and Presentations section of the investor website for a temporary access period.

What topics will Protara (TARA) management likely cover at the Feb–Mar 2026 investor events?

Management is expected to discuss clinical programs, development progress, and corporate strategy. According to the company, the fireside chats are part of investor conferences where the company typically presents program updates and near-term clinical milestones to investors and analysts.

Where is the Protara (TARA) investor webcast available online?

The webcast is available on the company’s Events and Presentations webpage at the investor site. According to the company, both the Oppenheimer and TD Cowen webcasts can be accessed via https://ir.protaratx.com and will be archived for a limited time after the events.